Metro Health Cancer Care

Wyoming, Michigan 49519

0 studies enrolling now · 4 studies all time

What they study most

Bladder Carcinoma, Breast Cancer, Multiple Myeloma, Renal Cell Carcinoma, Transitional Cell Carcinoma, Urothelial Carcinoma

Studies at this site

• PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations — Completed
• First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma — Stopped early
• Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma — Stopped early
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma — Completed